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The random cell migration of four human melanoma cell 
lines on laminin and type IV collagen - coated substrates was 
studied by video time-lapse image analysis and compared to 
the expression of a number of f31 integrins including CK.1f31' 
CK.2 f31' CK.3f31' and CK.6 f31 using flow cytometry. These integrins 
were h eterogeneously expressed in the four cell lines tested 
with three of four lines expressing CK.~1' The melanoma cell · 
line that did not express CK..jJ1 exhibited weak attachment and 
low cell migration rate on both laminin and type IV collagen, 
whereas the other melanoma cell lines showed an increase in 
attachment and m ean cell migration rate in a dose-dependent 
manner o n the matrix molecul es (p < 0.001). The enhanced 
T o invade, malignant tumor cells must be able to bind to the basement membrane, to digest it using protein-. ase activity, and to migrate into the surrounding tissue [1 ,2]. T o metastasize, th e invasive cell s must penetrate the vascul ar structures, enter the circulation, and fi-
nally bind to and invade the host tissue at the site of secondary tumor 
formation. Two extra-cellular matrix (ECM) proteins , laminin and 
type IV collagen, are important components of the basement mem-
brane at th e dermal epidermal junction and in the vascular structures 
of the primary and secondary sites. Laminin and type IV coll agen 
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Abbreviations: 
BSA: bovine serum albumin 
ECM: extra-cellular matrix 
EDTA: ethylenediaminetetraace tic ac id 
LN: lymph node 
MEM: minimal essential media 
MFI: mean fluorescence intensity 
MM-AN: metastatic melanoma cell line-code 
MM-RU: metastatic melanoma cel l line-code 
MoAb: monoclonal antibody 
PBS: phosphate-buffered sa line 
PM-WK: primary melanoma ce ll line-code 
RGP: radial growth phase component , 
RPM-EP: recurrent primary melanoma ce ll line-code 
VGP: vertical growth phase component 
VLA: very late antigen 
migration seen in the three cell lines could be specifically 
inhibited by function blocking anti-f31 and anti-CK.2 monoclo-
nal antibodies (p < 0.001) but not by function blocking anti-
CK.3 and anti-CK.6 monoclonal antibodies. Image analysis of the 
cells before and after treatment with anti-f31 and anti-CX2 
MoAb indicated that the inhibition of migration did not 
result in detectable cell detachment, retraction of cell proc-
esses, or other significant cell-shape change. Taken together, 
the findings suggest that the observable enhanced migration 
on laminin and type IV collagen of a number of human 
melanoma cell lines is largely m ediated by integrin CK.2 fJt· 
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have been shown to promote the attachment and to stimulate the 
migration of many cell types ir, lIitro [3 - 6] including melanoma 
[7 - 9] and the effects of these components on cells appear to be 
mediated by a number of cell surface ad hesion receptors including 
the PI integrin family. The integrins are a set of protein hetero-
dimers composed of one a and one P subunit. The PI integrin fam-
ily, also known as the VLA (very late antigen), share a common /11 
subunit combined with one among at least six possible a subunits 
[10,11] . Among them, integrins alPI and a2PI bind to laminin and 
type IV collagen; integrin a3PI binds to laminin, fibronectin , and 
type IV collage n; and a6PI is known as a monospecific laminin 
receptor. On the other hand, the heterodimers formed in combina-
tion with a. or as subunits are known to be fib ronectin receptors. 
Although non-integrin ECM receptors and recently characterized 
new a subunits have been identified, particularly in melanoma 
[12,13], PI integrin-mediated interactions with laminin and/or type 
IV collagen can be studied at least in part, in relation to the expres-
sion of alPI , a2PI , a3P, and a6PI integrins . 
The members of the PI integrin family have been intensively 
studied in relation to the malignant phenotype of diverse cell types 
[10] . Among the PI-integrins binding laminin and type IV collagen, 
integrin a2P, may playa role in invas ion and metas tasis. This inte-
grin has been recent! y reported to enhance the metastatic potential 
of rhabdomyosarcoma cell s [14] and to be biochemically identical to 
a previously described "melanoma progression antigen" [15 ,16] and 
upregulated in highly aggressive melanoma cells [17]. 
To further define the role of certain PI integrins in human mela-
noma, we studied the expression of laminin and type IV collagen 
receptors ofVLA- l to VLA-6 on four melanoma cell lines includino 
two primary and two metastatic melanoma cell lines. The func-
tional significance of these laminin and type IV collagen receptors 
within the PI integrin family was studied by substrate matrix mole-
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cule mediated increase of cell attachment and migration rate and 
specific anti-integrin subunit monoclonal antibody mediated inhibi-
tion assays itl lIi/ro. Our data indicate that a 2PI integrin plays an 
important role in laminin and type IV collagen mediated melanoma 
cell attachment and enhanced migration ill lIitro. 
MATERIALS AND METHODS 
Cell Lines and Cell Culture Human cutaneous melanoma cell 
lines were isolated as previously described [18] . Briefly, the PM-
WK cell line was obtained from approximately 10% of the original 
sterile fresh surgical specimen of primary cutaneous malignant mela-
noma, su perficial spreading type. The tissue fragments were washed 
~nd incuba ted in 0.25% trypsin at 37°C for 1 h. The epidermis was 
separated from the dermis using a dissecting microscope and a radial 
growth. phase (RGP) culture was obtained from explants of epi-
dermis ill media non-supportive of keratltlocytes. The RPM-EP cell 
line was established from a dermal nodule of a recurrent primary 
cutaneous m elanoma, thus representing the vertical growth phase 
(VGP) of primary cutaneous melanoma. MM-AN and MM-RU cell 
lines were derived from lymph node metastases . All ce ll lines have 
exhibited stable morphologies and growth properties for over two 
years and "Were confirmed as melanoma cells by anti - 5-100 protein 
antibody (Dako Corp) and antl-HMB-45 antibody (Enzo dlagnos-
tics, Inc.) testing. Precise characterization of these cell lines is de-
scribed in our previous report [18] . All cells were cultured in mini-
/Jlal essential media (MEM) with Earles balanced salt solution 
supplemented with 2% fetal bovine serum and 8% newborn calf 
serum and penicillin, streptomycin, and amphotericin B (Gibco 
Catalog Number 600-5240AG Antibiotic-Antimycotic). The cul-
cures were passed. at sub-confluence, approximately once a week, 
and kept in a 5% CO2 and 95% air humidified atmosphere. 
Antibodies and ECM Proteins Monoclonal antibody (MoAb) 
AlIB2 against the extra-cellular domain of the common PI integrin 
subunit of the VLA family [19] was kindly provided by Dr. Caroline 
H. Damsky (University of California, San Francisco, CA). The 
MoAb to alPI (Ts2/7) was provided by Dr. Martin E. Hemler 
(Dana-Farber Cancer Institute, Boston, MA) (20) . The MoAbs to 
[he 0'2 subunit (PIE6) and 0'3 subunit (PIB5) were purchased from 
relios Pharmaceuticals, Inc. (San Diego, CA) (21) . The MoAb to 
the 0'6 subunit (GoH3) was kindly provided by Dr. Arnoud Sonnen-
berg (Cenrral Laboratory of the N etherlands, Amsterdam, the 
Netherlands) [22] . The MoAb P3 (anti-Fc receptor) [23] was uti-
lized for flow-cytometry analysis as a negative control and MoAb 
W6/32 (specific for all major histocompatibility complex-I HLA 
heavy chains) was used as an unrelated specific MoAb control in the 
cell attachment and migration inhibition assays (American T ype 
Culture Collection). 
Laminin a nd type IV collagen (isolated by ion-exchange chroma-
tography from the basement membrane of the Engelbreth-Holm-
Swarm mouse tumor) were purchased from Collaborative Research 
Inc. (Bedford. MA). 
Flow·Cytometry Analysis Melanoma cells were obtained in 
suspension after trypsin ethylenediaminetetraacetic acid (EDTA) or 
EDTA treatment alone of the sub-confluent cultures and incubated 
for 30 min at 4°C with the MoAbs (approximate immunoglobulin 
G concentration was 1 to 2 J.lg/ml) described above at dilutions of 
1: 10 (conditioned medium containing MoAb AIIB2) or 1 : 1000 
(from ascites, all others), then washed three times and incubated for 
30 min with a 1/ 40 fluorescein-labeled goat -anti-rat (for MoAb 
GoH3) or goat- anti-mouse (for the other MoAbs) antiserum (Cap-
pel). The expression of PI . 0'1,0'2,0'3, and Ct6 integrin subunits was 
analyzed u s ing a Becton Dickinson FACScan II. Each cell line was 
also reacted with MoAb P3 (anti-Fc receptor) as a control. 
Cell Attachment Assay Attachment assays were performed in 
24-well plates (Primaria . Falcon. Lincoln Park, NJ) coated with the 
test ECM proteins followed by denatured bovine serum albumin 
(BSA) coating using established techniques. Briefly , laminin and 
type IV collagen were di luted to PBS to concentrations of 1.0, 10. 
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and 100 J.lg/ml and 1 ml of each solution was added to each well. 
The plates were kept overnight at 4 ° C and washed three times with 
PBS, and res idual protein binding sites were subsequently blocked 
by 12 h incubation with heat-denatured bovine serum albumin 
(Sigma, 20 mg/ml. 80 °C, 20 min) at 4°C as previously described 
(5). After three washings with PBS, 1 ml of serum-free medium 
(MEM) containing BSA (2 mg/ml) was added in each well and the 
plates were allowed to equilibrate at 37°C. 5% CO2 , 95% air for 30 
min . Cells were obtained in single-cell suspension with 0.02% 
EDTA and washed twice. and, after trypan blue viability testing, 105 
cells were added in each well and incubated at 3rC, 5% CO2 , 95% 
aiz: for 60 to 90 min. Preliminary studies at 15-, 30-, 60-, 90-. and 
120-min incubations determined that 15- and 30-min incubations 
were too short and 120-min too long to detect significant differ-
ences of cell attachment to the various substrates (data not shown). 
The wells were then uniformly washed three times with PBS to 
remove unattached cells and, lastly, the attached cells were collected 
by incubation with 0.25% trypsin and 0.02% EDTA (Gibco, Grand 
Island, NY) for 10 min. resuspended, and counted with a standard 
hemacytometer (Sigma) . Each experiment was conducted in tripli-
cate and mean attached cell number. standard deviation. standard 
error, and statistical significance (Student t test) were calculated. 
Cell.Attacbment-Inbibition Assay For inhibition experi-
ments. the MoAbs were used at concentrations of 2 to 10 J.lg/ml 
uS1l1g the fo llowing dilutions: 1 : 500 for W6/32 MoAb (used as a 
non~speClfic control MoAb) , 1: 3 for anti-PI AIIB2 (conditioned 
medIUm) MoAb, 1: 500 for anti-a 2 P1E6 MoAb, and 1: 500 for 
anti-a3 · These different MoAbs were added to the four different 
mel~noma cel l line suspensions prior to plating onto 96-wel l plates 
pre~lOus ly coated with either 0.1 ml of 10 J.lg/ml of collagen or 
lam1l1111. followed by denatured BSA blocking as described above. 
Tnrhcate wells were seeded with 2.5 X 104 cel ls per well for each 
antibody/ceil llJ1e mixture and following 60 min incubation, the 
number of attached cells was calcul ated by placing the center of the 
well under the 10 X obj ective field of the image-analysis system 
(descnbed below) and counting all the cell s in the field. A cursor 
covered each cel l to not count them twice. Counts in the field 
ranged from 35 to 680 cells. The ratio of the area of the entire well 
to the field area is 10 to I, thus the total number of attached cells per 
w~ll . IS 10 tlInes the cell count. Each experiment was conducted in 
tnplIcate and the data analyzed as outlined in the section above. 
Cell Migration Assay Micro-cover glasses (VWR ScientIfic 
Inc.) were coated with laminin, type IV collagen, and denatured 
BSA using the same procedure described for cel l attachment assays 
and kept in 35-mm tissue culture dishes (Miles Laboratories). Then, 
2.5 ml of serum free or 10% serum containing MEM was added and 
the dishes allowed to equilibrate at 37"C, 5% CO2 • 95% air for 30 
m1l1 and approximately 105 cells were seeded on micro coverslips to 
obtalJ1 a cell density bet~een 0.4 and 1.0 cell s/104 mm2 as previ-
ously descnbed [18) . Bnefly, cell cultures were observed under a 
lO X phase-contras t objective with a Nikol1 Diaphot inverted micro-
scope partially encased 111 a Plexiglas incubator housing and attached 
Nlkol1 1l1cubator NP-2 with stage thermostat and an air/C02 flow 
mixer to obtain constant temperature and pH. Cel l movements 
were record ed with a VIdeo camera attached to the video camera 
p~rt al~d connected to a time-lapse video cassette recorder. Cell 
mIgratIOn was recorded for 4 h between 4 to 30 h after plating. 
Previous experiments have shown that no significant difference 
eXIsts between mean migra tion rates obtained from observations 4 h 
and 30 h after pl ating nor signi ficant differences between serum or 
serum-free media if performed during the same interval (data not 
shown). Each migration experimen t recorded the pathways of25 to 
50 cells, and each experiment was repeated three times at each 
coating concentration of ECM component for calculation of mean 
migration rate standard deviation, standard error, and statistical sig-
nificance (Student t test). 
To determine the mean migration rate, the video images were 
played back at 1-h intervals and images were digi tally saved and 
migration pathways measured using a Microcomp image-analysis 
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system and software (Southern Micro Instruments, Atlanta, GA), 
us ing a personal computer with a video card using frame-grabbing 
digitizing software and a high-resolution video monitor. The data 
were saved as an MS-DOS (Microsoft) file and translated through a 
network (TOPS, Sun Microsystem Co., Berkeley, CA) to a Macin-
tosh SE for statistical analys is. Normalized migration paths were 
obtained by "grabbing" individual cell paths and "dragging" them 
without rotation so that the origin of all paths were superimposed 
on one central point. Phase-contrast photomicrographs were taken 
w ith a Nikon FE-2 camera attached to the inverted microscope . 
Cell-Migration-Inhibition Assay To detect changes in cell 
migration by the addition of function-blocking MoAb, the lowest 
substrate concentration were tested that demonstrated significant 
enhanced migration in each cell line (RPM-EP, MM-AN, and MM-
RU on 10, 100, and 10 ,ug/ml coating of lam in in, respectively, and 
10 ,ug/ml of collagen for all three lines). Because the line PM-WK 
did not show significant enhancement by either substrate, it was 
arbitrari ly tested at 10 ,ug/ml to control for non-specific or non-in-
tegrin mediated effects of th~ various MoAbs tested. The medium 
surrounding previously attached cells (for at least 4 h) was ex-
changed with temperature and pH-equilibrated MEM containing 
the various func tion-blocking and unrelated control MoAbs at the 
same concentrations described in the attachment-inhibition assays. 
The preparations were further equilibrated for 30 min before record-
ing the migration pathways. Ce ll area and cell shape (cell form 
factor) was quantified by image analysis prior to addition of MoAb 
and at the end of the assay to determine if reduction in migration 
was accompanied by cell rounding (retraction of processes) and/or 
detachment. Mean ce ll area and mean cel l form factor was deter-
mined on 10 randomly chosen cells (the first 10 cells encountered 
from the top of the video field) in each initial and final time frame 
for each experimental condition (MoAb and substrate). Area and 
form factoL" were calcul ated by planar morphometry software of the 
image-analysis system described in the previous section. Cell form 
factor is defined as 4n: X (area)/(perimeter)2 and is equal to 1 for a 
circle and increasingly less than 1 w ith increasing irregularity or 
angularity (elliptical, polygona l, polygonal with scall oping, dendri-
city, tripolar, bipolar) [24). Statistical analysis of migration rates was 
performed as described above and initial and final cell area and cell 
form factors were compared by paired Student t test. 
RESULTS 
Differential Expression of PI Integrin Subunits (VLA-l to 
VLA-6) to Laminin and / or Type IV Collagen in Human Mel-
anoma Cell lines There was heterogeneous expression of PI in-
tegrin subunits; each of our melanoma cel l lines exhibited a unique 
complement despite identical cu lture conditions (Fig 1). All lines 
expressed the PI integri n subunit as detected by the MoAb speci-
fic for this subunit: mean flu orescence intensity (MFI) was 27.0 
in PM-WK, 120.0 in RPM-EP, 150 in MM-AN, and 79.0 in 
MM-RU. 
Despite the heterogeneous expression among all the laminin and 
collagen binding integrin subunits tested, the most frequent expres-
sion was the 0'2 subunit, with expression in three of the four lines 
tested. The 0'2 integrin subunit appeared on the lines derived from 
later stages of tumor progression: expression was moderately de-
tected (10 ~ MFI < 50) in the recurrent and metastatic cell lines 
RPM-EP, MM-AN, and MM-RU (MFI = 38.3, 38.1 and 17 .3 re-
spectively). In contrast, the RGP primary melanoma derived cell 
line, PM-WK, showed a very low expression of the 0'2 integrin 
subunit (MFI = 4.5) (Fig l A ). 
T he other integrin subunits tested were less frequently repre-
sented. There was absent or very low expression of the 0'1 subunit on 
PM-WK and MM-RU (MFI < 5) and low expression of the 0'3 
subunit on PM-WK (MFI < 10) whereas RPM-EP and MM-AN 
expressed moderate levels of the 0'1 and 0'3 subunits (10 ~ MFI < 
50) (Fig 1B). Moderate expression of the 0'6 subunit was present 
only in MM-AN (MFI = 13.8) w hereas the others showed absent 
or very low expression (MFI < 5). Table I summarized the findings. 
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Figure 1. Integrin subu nit expression in human melanoma cells analyzed 
by flow cytometry. A) The level of fl, integrin subunit expression (dash~ 
lille) in the melanoma cell line PM-WK (lOp) is less than the cell lin~ 
RPM-EP (secolld fro III top) or the two metastatic melanoma cel l lines (MM· 
AN, third fro", top) and (MM·RU, bottolll) . T he 0:2 (VLA-2) expression (solid 
lillc) on PM-WK (top), is low or nearly absent, whereas there is moderate 
expression on RPM-EP cells and the metastatic ce ll lines. Negative control 
(fille dOlled lille) following incubation with anti-Fe receptor MoAb (P3). 
B) The 0:, (solid lille), 0:, (coarse dolted lille), and 0:6 (dashed lille) (VLA-l , 3 
and 6, respectively) subunit expression on PM-WK, RPM-EP, MM-AN, 
and MM-RU. 
The pattern of expression of these integrins on each cell line has 
remained constant over the las t 2 years. 
Differential Cell Attachment of Melanoma Cell Lines to La· 
minin or Type IV Collagen - Coated Substrates We investi· 
gated the attachment properties of these four human melanoma cell 
lines to substrates wi th increasing coating concentrations oflaminin 
and type IV collagen. RPM-EP, MM-AN, and MM-RU showed 
significantly enhanced attachment to laminin (p < 0.001) and [ 0 
type IV collagen (p < 0.001) in a dose-dependent manner (see Fia 
2). In contrast, PM-WK exhibited only a slight enhancement of 
attachment only to laminin and no enhancement to type IV colla· 
gen even at high coating concentrations. 
To further evaluate the role of PI integrins in cell attachment of 
these melanoma cell lines to laminin and type IV collagen, W~ 
conducted attachment inhibition experiments with these mela· 
noma cell lines using function-blocking MoAbs directed against the 
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Table I. Summary of Flow-Cytometry Data" of Expression 
of Integrin Subunits Tested 
Cell Line 
Primary Metastatic Melanoma 
Melanoma Origin Origin 
lntegrin PM-WK RPM-EP MM-AN MM-RU 
subunit RGP Derived VGP Derived LN Derived LN Derived 
p, ++ +++ +++ +++ 
(X, ++ ++ 
(X2 ++ ++ ++ 
a'~ + ++ ++ 
£1'6 ++ 
-: MfI was converted into se mi-quantitative format as fo llows: MFI < 5.0 defined as 
very low or absent (-), 5.0 :$ MFI < 10 as low (+), 10 S MFI < 50 as moderate (++), 
and MFI 2: 50 defined as high (+++). RGP, radial growth phase component; VGP, 
ve..rical growth phase component; LN, lymph node. 
p a2' Cl:'3' or a 6 subunits that have been reported to have an inhibi-[~ry. effect on cel l attachment [19,21,25,26). Incubation with an 
unrelated control MoAb, anti-a3 , and anti-a6 MoAb, did not signifi-
cantly inhibit cell attachment of all four cell lines to collagen or 
laminin (see Fi g 3). Furthermore, function-blocking anti-a2 and 
anti-P, MoAbs had no effect on attachment of the line PM-WK. 
However, anti-PI MoAb significantly inhibited (p < 0.001) the at-
tachment of the other three melanoma cell lines to type IV collagen 
and two of the three lines to laminin (see Fig 3). The cell line 
RPM-EP showed a slight but not significant reduction in binding to 
larninin with this MoAb. 
Likewise, treatment with function-blocking anti-a2 also signifi-
cantly reduced attachment (p < 0.001) of the MM-RU cells to both 
collagen and laminin (Fig 3d). In contrast, the anti-a2 significantly 
reduced a ttachment of the MM-AN cell s to type IV collagen but not 
laminin and this MoAb did not significantly reduce attachment of 
RPM-EP to laminin or type IV collagen (Fig 3b,c). 
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YJgllre 2_ Melanoma ceJJ attachment assay to heat-denatured 13SA/13SA 
@ccd substra tes or to various concentrations of laminin/BSA or type IV 
colJagen/BSA coated substrates. The melanoma cell line PM-WK (A) ex-
bibits less attachment to both laminin and type IV collagen than the other 
all lines (RPM-EP, MM-AN, MM-RU; B, C, and D, respectively). The 
laaer three lines (B, C, and D) show a significant dose-dependent increase in 
all attachment on both laminin and type IV collagen (Op < 0.001). Error 
/"1, standard deviation. 
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Figure 3. Cell adhesion assay on the effect of incubation with function-
blocking MoAbs directed against the P, , £1'2, a" or £1'6 subunits as compared 
to an unrelated control MoAb (anti-HLA class I) . Incubation with the anti-
a, and anti-a, MoAb did not inhibit cell attachment of all four cell lines to 
type IV collagen or Iaminin. The anti-a 2 (AII132) or anti-p, (PIE6) MoAb 
showed variable ability to inhibit PM-WK cells (A), RPM-EP cells (B) , 
MM-AN cells (C), or MM-RU (D) cells to both larrunin and collagen. 
(Op < 0.001) . Error bars, standard deviation. 
Differential Cell Migration of Melanoma Cell Lines on La-
minin and Type IV Collagen The effect oflaminin and type IV 
collagen - coated substrates on the mean random migration of 
human. melanoma cell s was investigated by image analysis of time-
lapse vl~eo reco:dings of individual cell migration pathways as de-
scnbed 111 Materials and Methods . The migration pathways revealed 
marked heterogeneous cell behavior among the cell lines in re-
sponse to I11creased substrate-coating concentrations of matrix mole-
cules.lntri~lsic differences in mean migration rates among the lines 
were IdentIfied; however, comparisons within a particular cell line 
to control substrates (BSA) and different ECM substrate concentra-
tions was most helpful to evaluate the differential haptokinetic re-
sponses. 
The mean random migration rates of all four cell lines in serum-
free media on control heat-denatured BSA coated substrate were 2, 
4,4, and 15,L111/ h for PM-WK, RPM-EP, MM-AN, and MM-RU, 
respectively. Indeed, the four cell lines maintained approximate 
relative intrinsic migration rates; PM-WK showed the lowest mi-
gration rate, RPM-EP and MM-AN intermediate rates, and MM-
RU the highest migration rate. In media containing 10% serum or 
in serum-free media (to eliminate a possible contribution of plasma 
fibronectin that could potentially coat the substrates during the 
experiment), a marked increase in mean migration rates on increas-
ing coating concentrations of laminin and collagen was observed. 
No significant difference in migration rate on the coated substrates 
was observed between serum or serum-free media. 
The mean migration rates for all cells in each experiment using 
the different ECM components was calculated and can be seen plot-
ted as vertical bars in Fig 4. The mean random migration rate of 
three of the four cell lines was significantly enhanced (p < 0.001) 
by both laminin and type IV collagen-coated substrates in a dose-
dependent manner (Fig 4) . However, the primary melanoma cell 
line PM-WK showed only a mild but not significant increase in 
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Figure 4. Bar graph of the mean random migration rates ofPM-WK (A), 
RPM-EP (B) , MM-AN (C), and MM-RU (D) on laminin- or type IV 
collagen - coated substrates shows a dose-dependent and significant enhance-
ment of migration in the latter three cel l lines. (*p < 0.001). Vertical bar, 
mean migration rate de ri ved from the migration paths of 75 to 150 cell s. 
Error bars, standard deviation. 
migration rate on th ese substrates. Interestingly, the enhanced mi-
gration rate of MM-RU cells on laminin at 10 .ug/mJ coating con-
centration was not observed at the highest coating concentration 
(100 .ug/ml). A similar pattern on type IV colJagen was observed 
with RPM-EP, although to a lesser extent because it was still signifi-
cantl y higher than the control migration rate on BSA alone. To 
investigate a role for PI integrins known to bind laminin or collagen 
in mediating the enhanced haptokinesis, we performed a number of 
function-bl ocking MoAb inhibition assays, described below. 
MoAb Inhibition of Enhanced Melanoma Cell Migration 
with Function-Blocking Anti-PI and Anti-a 2 To explore pos-
sible inhibition of the mi gration of the four melanoma cell lines on 
laminin and type IV coHagen -coated substrates, we used the func-
tion-blockin g MoAbs directed against the PI' a2 , a" or a 6 subunits 
th at were employed in the ceJJ-attachment studies outlined above. 
These MoAb have been reported to have an inhibitory effect on celJ 
attachment to these matrix molecul es [19,25 ,26]. 
Incubation with the unrelated control MoAb (W6/32), the fun c-
tion-blocking anti-a" or anti-a6 MoAbs did not significantly in-
hibit ce lJ mi gration of all four cell lines on coll agen or laminin 
coated substrates (see Fig 5). Likewise, fun ction-blocking anti-a2 
and anti-PI MoAb had no effect on cell migration of the line PM-
WK (Fig Sa) . H owever, both anti-PI and anti-a2 MoAb had a statis-
tically significant inhibitory effect (p < 0.001) on the mi gration 
rate of RPM-EP, MM-AN, and MM-RU (Fig 5h,e,d). Figure 6 
shows the effect of variable anti-PI and anti-a 2 MoAb concentration 
on the migration of MM-RU cell s. The anti-a } and anti-a6 MoAbs 
we re also tes ted at three- to tenfold hi gher concentrations and no 
significant inhibition was detected in all the cell lines . 
The time-lapse video tapes revealed th at treatment of the mela-
noma cells with the MoAbs, in particular the anti-PI MoAb or 
anti-a 2 MoAb, did not induce detachment of th e cells from either 
th e laminin- or collagen-coated substrates, even following several 
hours of incubation, because the cells continued to migrate at rates 
of 3- 5 .um/ h for RPM-EP and MM-AN and 10 - 12 .um/ h in th e 
case of MM-RU. Image analysis of individual cells using planar 
morphometry before and after addition of MoAb provided furth er 
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Figure 5. Cell-migration assay on the effect of incubation with function-
blocking MoAbs directed against the P, , a2 , a 3 , or a6 subunits as compared 
to no MoAb treatment or to an unrelated control MoAb (anti-HLA class fl. 
The anti-p, MoAb (AIIB2) and anti-a2 MoAb (P1E6) did not inhibit the 
migration of the PM-WK cell line (A), whereas they significantly inhibit 
the migration rate of the RPM-EP (B), MM-AN (C), and MM-RU (D) cell 
lines oniaminin- or type IV collagen- coated substrates (*p < 0.001) . Verii-
ca l bars, migration paths of approximately 25 to 50 cells. Error bars, standard 
deviation. 
evidence that the inhibition of migration by the MoAb was not the 
result of cell detachment or cell retraction of processes. The cell 
form factor (see Materials alld Meth ods) for round, detached cells 
resting on the substrate before cell spreading ranged from 0.76 to 
0.93 with a mean of 0.87 ± 0.02. W ell-spread round cells also had 
form factors above 0 .75 whereas, at the other end o f the spectrum, 
bipolar or dendritic cells have form-factor values less than 0.20. In 
fact, th e mean cell form factors in the various experimental condi-
tions ranged from 0.46 ± 0.3 to 0 .62 ± 0.4 for RPM-EP, 0.41 ± 
50,--------------------. 
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Figure 6. Effect of increas ing concentration of the anti-p, MoAb (AIm ) 
and anti-a 2 MoAb (P1E6) on the migration rate of MM-RU cells. Error bars, 
standard deviation. 
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0.03 co 0.56 ± 0.05 for MM-AN, and 0.43 ± 0.04 to 0.52 ± 0.05 
for MM-R U and no significant difference was detected using paired 
Student t test between initial and post-MoAb treatment using anti-
p and anti-a2 MoAb on either laminin or collagen substrates. Like-,\~ise, mean cell areas (±SD) on the matrix molecule-coated sub-
strates before and after MoAb treatment ranged from 968 ± 79 to 
1249 ± 122 Ilm2 for RPM-EP, 520 ± 48 to 707 ± 99 Ilm2 for 
MM-AN, and 701 ± 85 to 990 ± 85 11m2 for MM-RU. No signifi-
cant difference in projected area was detected usin g paired Student t 
test between initial and post-MoAb treatment using anti-p. and 
anti-a 2 MoAb on either laminin or collagen substrates. As a refer-
ence, mean projected area of non-atcached, round cells resting on 
the substrate immediately after cell plating and before cell spreading 
ranged from 97 to 215 11m2. Taken together, the decreased migra-
tion but not total inhibition of migration and the area and form-fac-
tor data indicate that the inhibition of migration by the anti-PI and 
anti-0'2 MoAb did not involve cell retraction of processes, detach-
ment, and/or cel l rounding. 
DISCUSSION 
Cell adhesion and cell migration are essential steps in the invasive 
and metastatic behavior of malignant cells. Malignant cell binding 
to the basement membrane and cell migration are believed to be 
involved in primary-site infiltration during the invasive step of 
!lunor progression and in the colonization of the secondary site in 
[he metastatic step [1 J. Some of the members of the PI lI1tegnn 
family are specifically directed towards components of the basement 
membrane. Among them, the a.PI, az/l l , and aJJI integrins are 
'Nell characterized and exhibit a high affinity for laminin and/or 
tvpe IV collagen, which are two major components of the basement 
membranes [11, 13,27J. New PI integrins continue to be character-
ized including (X7PI' a laminin receptor that has been described ill 
llJ el~noma cells [1 2, 13J. We have restricted our study to VLA-1 to 
VLA-6 integrins because of the availability of these antibodies for 
detection and, more importantly, function-blocking studies. The PI 
inregrins appear to be connected by their intra-cellular domain to 
components of the cytoskeleton. [28 ,29] and may participate in the 
Illechanisms responSible for active cell movement. Moteovet, la-
minin and type IV collagen have been shown to enhance the motil-
ity of either normal or malignant cell types jn pjtro [3 - 9 ,30,31] and 
l(verallines of eVidence suggest that the azfll II1tegnn appears to be 
In important marker for the malignant phenotype [14]and espe-
cially in melanoma where It has been shown to be associated With 
later stages of tumor progression and aggressive melanoma cell lines 
115 - 17]. Fu~therll1ore, anti-PI and anti-a2 Mo~bs ha~e been shown 
to inhibit migration of tull10r cells 111 three-duuenswnal col lagen 
gels [32].. . . 
The aim of thiS study was to further II1vestlgate the role of the PI 
integrins that .b.ind to laminin and type IV collag~n in two of the 
potentially cntlcal steps of invaSion and metastaSIS: cell ad l~ eslon 
and in particular, cell motility . We II1vestigated the expressIOn of 
the;e receptors in a number of our recently characterized human 
11Jclanoma cell lines that were isolated from different stages of 
tumor progression to detect differences that might provide insight 
inro their different behavior on specific ECM components. 
The relative expression of the Pt, at, a 2 , a), and a 6 integrin 
lubunits was elucidated by flow cytom.etry on four of our cu ltured 
human melanoma cell lines . The expression of these laminin and/ or 
type IV ~ollagen receptors is heteroge?eous among the four cell 
lines studied, slmtlar to prevIOUS studies 10 melanoma (16,33J. Nev-
frtheless, heterogeneous expression determines differential adhe-
live behavior to specific ECM molecules [34] or relates to tumor 
progression (16,17]. Although our sample of cell lines studied is 
lmall because our primary focus is on cell-migtation functional 
lIsays, it is interesting nevertheless that the az subunit was common 
to the three cell lines derived from later stages of tumor progression, 
Consistent with the findings by Klein el af [16J . Furthermore, the 
~k of expression of this integrin in PM-WK cells derived from a 
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pre-invasive melanoma and the exptession in invasive and meta-
static derived cells also supports the work describing it as a marker of 
melanoma progression [15,16J. Future migration functional studies 
directed towards the p) integrin subunit, another receptor showing 
expression in melanoma from later stages of progression [33], may 
lead insight into other integrins involved in cell motility. 
The attachment of human melanoma cells derived from invasive 
or metastatic tumors was significantly enhanced by substratum-
bound laminin Or type IV collagen in a dose-dependent manner. 
The intra-epidermal derived cell line (PM-WK) did not show en-
hanced attachment to collagen in the coating concentrations tested, 
and although mild enhanced attachment to laminin was observed, it 
was not as significant as the invasive or metastatic lines derived cell 
lines. This observation may relate to the low invasiveness and lack 
of metastatic behavior displayed by intra-epidermal primary mela-
noma cells pathologically [35 - 37] and experimentally [38 ,39]. 
To characterize wh ich integrins were the predominant ones 'in-
volved in cell attachment to type IV collagen and laminin in these 
human melanoma cell lines, we incubated the cells with a number of 
function-blocking MoAbs including anti-PI' anti-(Xz, anti-a), and 
anti-(X6 MoAbs. We found that the attachment profiles of all mel a-
noma lines in the presence of these MoAb to be heterogeneous, 
reflecting, at least in part, the heterogeneous expression of PI inte-
grins on these cell lines as determined by flow cytometry. The 
PM-WK cell line. expressed li ttle or no a 2 , a ), or a 6 , attached 
poorly to both substrates and the function-blocking MoAb against 
these integrins had no effect on binding. Surprisingly, anti-pt did 
not completely inhibit this mild attachment, even though the cells 
express PI integrin, suggesting that other non-PI integrin collagen 
and laminin receptors are mediating this low level of attachment. In 
contrast, the cell line MM-RU, expressing only the a2 subunit 
among the VLAs tested, was highly adhesive to type IV collagen 
and laminin and this attachment was significantly inhibited by anti-
PI MoAb as well as with anti-a2 MoAb, suggesting that most of the PI integrin related adhesion to these ECM substrates is mediated by 
az/ll integrin. 
The other two cell lines showed intermediate profiles of attach-
ment in the inhibition assays. The anti-PI antibody inhibited attach-
ment of the MM-AN cells (which expresses the PI' a2 , a l , and a6 
subunits) to both co llagen and laminin and the anti-a2 MoAb inhib-
ited attachment to type IV collagen and reduced but did not signifi-
cantly inhibit the attachment to laminin, indicating that tl:e a) or a 6 
subunits may contribute to binding to this latter substrate, How-
ever, the MoAb against the a l or a 6 subunits did not inhibit this 
attachment, suggesting that the presence of another PI integrin 
subunit that is involved in binding to laminin is sufficient to permit 
adhesion . Again , it is possible that it is the a7PI laminin receptor 
recently reported on melanoma cells [12,13J. Likewise, the RPM-
EP cell line (which expresses the PI' a 2 , and a l subunits) also had a 
unique attachment profile with the MoAb treatment: the anti-PI 
MoAb was able to inhibit significantly attachment to type IV colla-
gen but not laminin and the anti-a2 did not inhibit significantly 
attachment to both substrates. These findings lend further support 
that certain melanoma cell lines utilize non-PI integrins for cell 
attachment. Other f3 integrin subunits may be involved, including 
p) integrin subunit as indicated above [33J. 
We were not able to detect inhibition of attachment of any of the 
cell lines with the anti-a) or anti-a6 MoAbs alone. Future studies 
using combinations of these and other function-blocking MoAbs 
may help dissect the relative contribution of adhesion receptors for 
each cell line; however. numerous studies have pursued this ap-
proach and, because we detected a significant contribution of azfll Jl1 
cell attachment, we w ished to focus on the possible role of azPl on 
cell migration. 
T he effect oflaminin- and type IV collagen-coated substrates on 
melanoma mean random. cell migration (haptokinesis) ill vitro was 
similarly examined by stimulation and inhibition assays on the four 
melanoma cell lines. A sign ificant dose-dependent acceleratIon of 
the migration rate on laminin and type IV collagen was observed 111 
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the azBl-positive cell lines. In contrast, the PM-WK cell line re-
mained significantly less motile on both substrates and lacked azBl 
integrin. The lack of azBl expression, poor attachment to the sub-
strate, and low migration rate may be related to other factors affect-
ing motility such as down-regulation of certain cytoskeletal pro-
teins [40] . Nevertheless, the relationship of azBl integrin expression 
to the acceleration in cell migration induced by laminin- and type 
IV coll agen-coated substrates was indicated by the experiments 
demonstrating the significant inhibition of acceleration by the addi-
tion of either anti-a2 or anti-PI MoAb. Surprisingly, unlike the 
attachment studies, the RPM-EP, MM-AN, and MM-RU cell lines 
all showed simil ar migration-inhibition profiles following treat-
ment with the various function-blocking MoAbs. The lack of con-
cordance between abil ity of anti-a2 or anti-PI antibodies to inhibit 
attachment and to inhibit migration on laminin or coll agen in the 
RPM-EP and MM-AN cell lines may be due to reports that specific 
integrins involved in initial ce ll adhesion can differ from those 
involved in migration [32]. It is possible that production of endoge-
nous matrix molecules in theJonger migration assay may contribute 
to this finding; however, the discrepancy observed in the RPM-EP 
and MM-AN lines may also be the result of the other integrin 
subunits that were identified that are known to promote adhesion 
but apparently do not playas critical a role in cel l migration as the a 2 
subunit. Cell locomotion involves not only adhesion, but also signal 
transduction to engage the cytoskeleton associated proteins, as well 
as other molecules for subsequent cyclical attachment and detach-
ment. N evertheless, the simil ar inhibition of migration to baseline 
(denatured BSA rate) by on ly anti-a2 or anti-PI MoAb suggests that 
most of the enhanced migration is due to a2PI' The reduction in 
migration is not due to detachment or rounding of the ce lls due to 
retraction of cell processes because the morphometric data indicate 
no significant change in projected surface area or shape following 
treatment with anti-a2 or anti-PI' Presumably the other integrin 
and non-Integrin receptors prevent retraction of the cell processes. 
The mechanism by which this integrin enhances cell migration on 
collagen and laminin is unclear, but may be simply due to increased 
traction afforded by the direct binding to ligand or may involve a 
complex pathway involving signal transduction to engage cytoskel-
etal proteins. Recent studies on integrin-mediated enhanced migra-
tion on fibronectin suggests that cell tension transmitted to the 
ECM via the cytoskeleton may involve the association of PI inte-
grins with specific actin-associated proteins including tal in, vincu-
lin, and/or a-actinin [28,41-43] . Furthermore, migration of fibro-
blasts on type I collagen has been shown to be inhibited by the same 
MoAbs we have used in this study, and regulation of this a2PI 
mediated migration is mediated in part by shifts in concentrations of 
extracellul ar M g++ and Ca++ [44]. 
Taken together our data indicate that cultured melanoma cells 
demonstrate heterogeneous behavior not only with regard to cel l 
attachment but also cell migration on laminin and/or type IV colla-
gen. These data also confirm that these differences are largely me-
diated by differential ex pression of members of the PI integrin fam-
ily. That the a 2p, heterodimer may playa functionally predominant 
role is suggested by the following data: 1) the low motility on both 
substrates and the low expression of a2PI in the PM-WK cell line; 
2) a 2PI is the on ly PI integrin expressed in all three cell lines that 
demonstrate high affinity and increased migratory response to both 
substrates; 3) the g reatest motility in these four cel l lines was ob-
served in the line expressing only a2PI; and 4) the anti-a2 subunit 
MoAb reproduced the inhibitoty effect of anti-PI MoAb on cel l 
migration rate on both substrates in all three lines. 
Our data are in accordance with the previously described effect of 
laminin and type IV collagen on melanoma cell migration [3 - 9] 
and indicate a role of at least some PI heterodimers, and, in particu-
lar, (X2PI , for binding to these substrates. The present data support 
the hypothesis of the importance of the expression of (X2PI as a 
malignant phenotype [14 - 17] and indicate a functionally predomi-
nant role for this integrin not on ly in melanoma cell attachment but 
also cell migration on laminin and type IV collagen ill vitro. These 
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findings may provide further insight into understanding melanoma 
metastases ill vivo. 
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